Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS ISSUE:
September 2011

Vilazodone (Viibryd) Part II
Evidence to date shows no significant benefit of the new selective serotonin reuptake inhibitor (SSRI) vilazodone (Viibryd) over other antidepressants.

Remember Clozapine
Clozapine (Clozaril and others) carries a wide range of side effects, but it is still the most efficacious antipsychotic when patients are inadequately responsive to other agents.

In Brief
New Cardiac Warning Added to Labeling for Quetiapine (Seroquel); Atomoxetine (Strattera) Does Not Attenuate Weight Gain in Patients with Schizophrenia

No Help from the "Sunshine Vitamin"
In a nonclinical elderly population, vitamin D supplementation had no significant effect on mood or other mental health outcomes.

In Brief

September 2011

In July, the US Food and Drug Administration requested that AstraZeneca add a new warning to the labeling for quetiapine (Seroquel) and extended-release quetiapine (Seroquel XR) stating that they should not be used concomitantly with certain medicines that prolong the QT interval (Wilson D. NY…

To view the rest of this article, please: